Laws, Protections and Public Policy
September 05, 2024
Bright Pink and FORCE
Posted in...:
Laws, Protections And Public Policy
Tags:
Patient Advocacy ,
Breast Screening ,
Brightpink ,
Accesstocare
June 14, 2023
Reflections on 10 Years Without Gene Patents
Posted in:
Laws, Protections And Public Policy
Tags:
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Advocacy ,
FORCE
May 01, 2023
What is Legal about Cancer?
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
June 15, 2022
Advocacy Spotlight: Increasing Our Focus on State Level Issues
Posted in:
Laws, Protections And Public Policy ,
Partnerships
Tags:
Cancer Advocacy ,
Patient Advocacy ,
Cancer Policy
February 19, 2020
New Medicare Genetic Testing Policy: What Does It Mean to Me?
Posted in:
Laws, Protections And Public Policy
Tags:
Hereditary Cancer ,
Genetic Testing ,
Medicare ,
Multigenetesting ,
Tumorbiomarker
July 11, 2019
Protect Yourself, Your Friends and Family from Fraudulent Genetic Testing
Posted in:
Laws, Protections And Public Policy
Tags:
Hereditary Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2
May 30, 2019
Alert: Cancer Genetic Testing Should Be Performed in the Health Care Setting
Posted in:
Laws, Protections And Public Policy ,
Genetic Testing
Tags:
Hereditary Cancer ,
Genetic Counseling ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Inherited Mutations ,
23andme
February 22, 2019
FORCE and Other Groups Meet with the Centers for Medicare and Medicaid Services (CMS)
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Hereditary Cancer ,
Hereditary Cancer Research ,
Screening And Prevention ,
PALB2 ,
ATM
February 28, 2018
Five Year Ovarian Cancerversary
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Ovarian Cancer
October 12, 2017
Patients Weigh In On Review of PARP Inhibitors for Treatment of Ovarian Cancer
Posted in:
Laws, Protections And Public Policy ,
Cancer Treatment
Tags:
Ovarian Cancer ,
PARP Inhibitor ,
Patient Advocacy
September 19, 2017
Insurance Coverage for Clinical Trial Participation: Significant Barriers Remain
Posted in:
Laws, Protections And Public Policy ,
Research
Tags:
Clinical Trials ,
Medicare ,
Insurance ,
Insurance Coverage ,
Medicaid
May 11, 2017
Fueling Patient-Focused Health Care
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Hereditary Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
HBOC ,
Personalized Medicine ,
Health Policy ,
Patient Advocacy
April 23, 2017
Reflections on the March for Science
Posted in:
Laws, Protections And Public Policy ,
FORCE And FORCE Impact
Tags:
Research ,
Insurance Coverage ,
March For Science ,
Science
January 26, 2017
Flawed Research and Reporting on the “Angelina Effect” Could Threaten Access to HBOC Care
Posted in:
Laws, Protections And Public Policy ,
XRAY
Tags:
BRCA ,
Hereditary Cancer ,
Breast Cancer ,
Hereditary Cancer Research ,
Genetic Testing ,
Prophylactic Mastectomy ,
BRCA2 ,
Previvor ,
HBOC ,
PALB2 ,
CHEK2 ,
ATM
August 06, 2012
Applying Personalized Medicine to Disease Screening and Prevention
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Genetics ,
Hereditary Cancer ,
Breast Cancer ,
Cancer Prevention ,
Hereditary Cancer Research ,
Ovarian Cancer ,
Genetic Counseling ,
Genetic Testing ,
Prophylactic Mastectomy ,
BRCA1 ,
BRCA2 ,
Prophylactic Surgery ,
Survivor ,
Ovarian Cancer Early Detection ,
HBOC ,
Prostate Cancer ,
PSA ,
USPSTF ,
Early Detection ,
Personalized Medicine ,
Screening And Prevention
June 01, 2012
13 Facts that Men with Hereditary Cancer Risk Should Know
Posted in:
Laws, Protections And Public Policy ,
Men With Mutations
Tags:
BRCA ,
Genetics ,
Breast Cancer ,
Cancer Prevention ,
Genetic Counseling ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Previvor ,
Survivor ,
Prostate Cancer ,
USPSTF
November 10, 2009
Direct-to-consumer genetic testing: the latest FORCE testimony to SACGHS and FDA feedback
Posted in:
Laws, Protections And Public Policy
Tags:
July 17, 2009
FORCE and Health Care Community Letter in Support of the EARLY Act
Posted in:
Laws, Protections And Public Policy ,
Research
Tags: